Table 1.

Characteristics of histologic findings in published case series

ReferenceCPIOther ATIN DrugsKidney Biopsy
Shirali et al. (10) (n=6)3 Nivo5 PPI6 ATIN
2 Pembro1 NSAID
1 Ipi+nivo
Cortazar et al. (1) (n=13)6 Ipi6 PPI12 ATIN
1 Nivo1 NSAID1 TMA
2 Pembro3 Antibiotics
4 Ipi+nivo
Izzedine et al. (18) (n=12)12 Pembro05 ATI
4 ATIN
1 MCD+ATI
1 MCD
1 NF
Mamlouk et al. (17) (n=16)6 Nivo9 PPI5 ATIN
6 Pembro3 NSAID9 ATIN+GN
2 Ipi+nivo3 Antibiotics1 ATI
1 Atez1 NF
1 Trem
  • CPI, checkpoint inhibitor; nivo, nivolumab; PPI, proton pump inhibitor; ATIN, acute tubulointerstitial nephritis; pembro, pembrolizumab; NSAID, nonsteroidal anti-inflammatory drug; ipi, ipilimumab; TMA, thrombotic microangiopathy; ATI, acute tubular injury; MCD, minimal change disease; NF, nonspecific findings; atez, atezolizumab; trem, tremelimumab.